Open AccessP652: MEASURING MINIMAL RESIDUAL DISEASE BEYOND 10‐4 THROUGH IGHV LEADER‐BASED NEXT GENERATION SEQUENCING IMPROVES PROGNOSTIC STRATIFICATION IN CHRONIC LYMPHOCYTIC LEUKEMIA
Author(s) -
Hengeveld P.,
Klift M.,
Kolijn P. M.,
Davi F.,
Kavelaars F.,
Jonge E.,
Robrecht S.,
Assmann J.,
Straten L.,
Ritgen M.,
Westerweel P.,
Fischer K.,
Goede V.,
Hallek M.,
Levin M.D.,
Langerak A.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000845492.79622.ef
Subject(s) - ighv@ , minimal residual disease , chronic lymphocytic leukemia , medicine , oncology , dna sequencing , primer (cosmetics) , leukemia , biology , immunology , dna , computational biology , microbiology and biotechnology , genetics , chemistry , organic chemistry